# Aqtual

**Canonical:** https://apis.io/providers/aqtual/  
**Website:** https://aqtual.com/  
**APIs profiled:** 0

Aqtual, Inc. is a Hayward, California precision-medicine company founded in 2019 by Diana Abdueva (Founder and CEO) and co-founder Rich Rava, developing blood-based diagnostics on a proprietary "active chromatin" cell-free DNA (cfDNA) platform. Rather than reading cfDNA for mutations alone, Aqtual captures the previously unexplored cfDNA fragments bound to active chromatin, so a single routine blood draw reports on DNA, epigenetic regulation and protein-DNA binding together — surveying on the order of 200,000 gene promoters, 400,000 enhancers, 50,000 insulators, 20,000 silencers and a million transcription-factor binding sites. Its lead product is a therapy-response prediction test for rheumatoid arthritis, evaluated in the prospective PRIMA-102 observational trial (NCT05936970), with oncology programs in leiomyosarcoma immunotherapy response and early colorectal cancer detection, and stated expansion into immunology, cardiovascular, metabolic and neurological disease. The company raised a USD 16 million Series A in October 2023 and over USD 31 million in Series B funding announced July 2025 from Bold Capital, the Bold Longevity Growth Fund, Genoa Ventures, Manta Ray Ventures and Yu Galaxy. Aqtual is a clinical-diagnostics and life-sciences business, not a software vendor: as of August 2026 it publishes no developer portal, no API documentation and no machine-readable API contract of any kind, and every /.well-known/ and contract-discovery path on aqtual.com returns 404.

## Kin Score — 6.4 / 100 (minimal)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (+0.0 from 6.4).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 13.8 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Aqtual Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Precision Medicine, Diagnostics, Liquid Biopsy, Cell-Free DNA, Epigenetics, Genomics, Biotechnology, Oncology, Rheumatology, Healthcare, United States

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/aqtual/). Scores are computed from the provider's own public artifacts under a published rubric.